Imsidolimab

Chemical Properties

CAS No.	2102543-86-0	Cat. No.	BCP46705
Name	Imsidolimab
Synonyms	ANB019;
Formula		M. Wt

Biological Activity

Description	Imsidolimab (ANB 019) is an antibody that inhibits the function of the interleukin-36-receptor, or IL-36R, which we are developing as a potential first-in-class therapy for patients suffering from generalized pustular psoriasis (GPP) and moderate-to-severe hidradenitis suppurativa.

Description

Imsidolimab (ANB 019) is an antibody that inhibits the function of the interleukin-36-receptor, or IL-36R, which we are developing as a potential first-in-class therapy for patients suffering from generalized pustular psoriasis (GPP) and moderate-to-severe hidradenitis suppurativa.

Structure

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Service & Tech Support:orders@biochempartner.com

Website:www.biochempartner.com

Products are for research use only and not for human use. We do not sell to patients.